| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in HCC patients
|
Guarino, M.
|
|
2014
|
46 |
S4 |
p. e137-
1 p.
|
article
|
| 2 |
Clinical and prognostic relevance of albumin dimers in patients with cirrhosis: A novel identified structural alteration of the molecule
|
Baldassarre, M.
|
|
2014
|
46 |
S4 |
p. e130-
1 p.
|
article
|
| 3 |
Editorial board
|
|
|
2014
|
46 |
S4 |
p. i-
1 p.
|
article
|
| 4 |
Effectiveness of beta-blocker in primary prevention of variceal bleeding in patients with cirrhosis: A prospective evaluation by hepatic venous pressure gradient measurement
|
Butera, G.
|
|
2014
|
46 |
S4 |
p. e141-
1 p.
|
article
|
| 5 |
Effects of non-selective β-blockers on hemodynamics and paracentesis induced circulatory dysfunction in patients with cirrhosis undergoing large volume paracentesis
|
Ferrarese, A.
|
|
2014
|
46 |
S4 |
p. e138-
1 p.
|
article
|
| 6 |
Efficacy and safety of long-term therapy with Entecavir (ETV) or Tenofovir (TDF) in patients with HBV-related cirrhosis
|
Fasano, M.
|
|
2014
|
46 |
S4 |
p. e140-
1 p.
|
article
|
| 7 |
Gut-stimulated inflammasome activation drives progression of liver injury in NASH
|
Gemini, S.
|
|
2014
|
46 |
S4 |
p. e140-
1 p.
|
article
|
| 8 |
Healthcare costs of treating patients with overt hepatic encephalopathy in Italy
|
Roggeri, D.P.
|
|
2014
|
46 |
S4 |
p. e131-e132
nvt p.
|
article
|
| 9 |
Hepatitis delta virus (HDV) coinfection among patients with HBsAg positive cirrhosis. An analysis the MASTER-B cohort
|
Brancaccio, G.
|
|
2014
|
46 |
S4 |
p. e135-
1 p.
|
article
|
| 10 |
Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT)
|
Zanetto, A.
|
|
2014
|
46 |
S4 |
p. e138-
1 p.
|
article
|
| 11 |
Impact of occult HBV infection in HCC presentation in HCV-related cirrhosis
|
Coppola, N.
|
|
2014
|
46 |
S4 |
p. e134-
1 p.
|
article
|
| 12 |
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management
|
Okolicsanyi, S.
|
|
2014
|
46 |
S4 |
p. e129-
1 p.
|
article
|
| 13 |
Mycophenoalatemofetil monotherapy in liver transplantation
|
Zingone, F.
|
|
2014
|
46 |
S4 |
p. e136-
1 p.
|
article
|
| 14 |
No differences of response to telaprevir based therapy in cirrhotic and non cirrhotic patients with RVR: Real life data from South Italy
|
Persico, M.
|
|
2014
|
46 |
S4 |
p. e134-e135
nvt p.
|
article
|
| 15 |
Overexpression of the genetic effector pathway of inflammosome in peripheral blood mononucleated cells of patients with acute-on-chronic liver failure
|
Gola, E.
|
|
2014
|
46 |
S4 |
p. e131-
1 p.
|
article
|
| 16 |
Percutaneous implant of Denver peritoneovenous shunt for treatment of refractory ascites
|
Piccirillo, M.
|
|
2014
|
46 |
S4 |
p. e139-
1 p.
|
article
|
| 17 |
Portal vein thrombosis in cirrhosis: Predictors of successful anticoagulation therapy
|
Rodriguez-Castro, K.I.
|
|
2014
|
46 |
S4 |
p. e132-
1 p.
|
article
|
| 18 |
Potential net health benefit of pre-transplant Sofosbuvir to prevent recurrence of HCV infection after liver transplantation: A multicenter, cohort model study
|
Vitale, A.
|
|
2014
|
46 |
S4 |
p. e132-e133
nvt p.
|
article
|
| 19 |
Quality of sleep in patients with liver transplantation
|
Zingone, F.
|
|
2014
|
46 |
S4 |
p. e137-
1 p.
|
article
|
| 20 |
Reappraisal of prognostic value of MELD-Na score: A new tool for liver transplant prioritization in HCV-infected patients
|
Bruno, S.
|
|
2014
|
46 |
S4 |
p. e129-e130
nvt p.
|
article
|
| 21 |
The impact of nucleoside/nucleotide analogues on the natural history of patients with HBV-related cirrhosis: A prospective comparative study towards patients with HCV-related cirrhosis in the interferon and ribavirin era
|
Piano, S.
|
|
2014
|
46 |
S4 |
p. e141-
1 p.
|
article
|
| 22 |
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene
|
Bronte, F.
|
|
2014
|
46 |
S4 |
p. e136-e137
nvt p.
|
article
|
| 23 |
Transplantation of stem/progenitor cells isolated from human fetal biliary tree into two patients with advanced liver cirrhosis
|
Cardinale, V.
|
|
2014
|
46 |
S4 |
p. e139-e140
nvt p.
|
article
|
| 24 |
Treatment type is an independent prognostic factor for patients with intermediate stage hepatocellular carcinoma
|
Pecorelli, A.
|
|
2014
|
46 |
S4 |
p. e131-
1 p.
|
article
|
| 25 |
Tumorigenic potential of cancer stem cells (CSCs) isolated from human cholangiocarcinoma (CCA) subtypes in cirrhotic liver
|
Torrice, A.
|
|
2014
|
46 |
S4 |
p. e133-
1 p.
|
article
|
Journal description